Medical/Health

Johnson & Johnson faces a new proposed class action lawsuit that alleges the pharma giant’s ubiquitous Band-Aid products, unbeknownst to consumers, contain toxic “forever chemicals,” which can be harmful to humans even at very low levels.

Four consumers filed a lawsuit alleging that Stanley-brand cups contain lead and the maker failed to disclose this until January 2024.

A class action alleges the maker of the Omron Platinum Upper Arm Blood Pressure Monitor has defrauded thousands of consumers in that blood pressure readings from the device are “wildly inaccurate.”

23andMe faces a proposed class action lawsuit that alleges lax cybersecurity is to blame for a massive early-October 2023 data breach, which has reportedly resulted in users’ sensitive genetic and ancestry information going up for sale.

Philips will pay at least $479 million to settle class action claims from individuals and entities that used or paid for nearly 11 million CPAPs, BiPAPs and ventilators recalled by the company in June 2021.

A proposed class action alleges Harvard University was negligent in failing to prevent a former morgue manager from mishandling and selling the body parts of cadavers donated to the Ivy League heavyweight’s medical school.

A proposed class action alleges certain Fitbit fitness trackers are falsely advertised in that they are unable to accurately measure the blood oxygen (SpO2) levels of users with darker skin.

Eli Lilly & Co. has agreed to pay $13.5 million and cap the price of insulin for four years to settle long-running class action litigation that alleged the pharma company illegally colluded to drive up the price of the life-saving diabetes medication.

BetterHelp faces at least two putative class action lawsuits after being hit with a proposed Federal Trade Commission (FTC) consent order banning the online counseling platform from sharing consumers’ data with third parties.